KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Other financing activities (2016 - 2025)

Cardinal Health's Other financing activities history spans 17 years, with the latest figure at -$1.0 million for Q4 2025.

  • For Q4 2025, Other financing activities fell 107.69% year-over-year to -$1.0 million; the TTM value through Dec 2025 reached -$79.0 million, down 363.33%, while the annual FY2025 figure was -$13.0 million, 128.26% down from the prior year.
  • Other financing activities for Q4 2025 was -$1.0 million at Cardinal Health, up from -$80.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $45.0 million in Q2 2023 and bottomed at -$80.0 million in Q3 2025.
  • The 5-year median for Other financing activities is $2.5 million (2023), against an average of $150000.0.
  • The largest annual shift saw Other financing activities surged 2200.0% in 2022 before it tumbled 185.71% in 2025.
  • A 5-year view of Other financing activities shows it stood at $1.0 million in 2021, then soared by 2200.0% to $23.0 million in 2022, then increased by 26.09% to $29.0 million in 2023, then crashed by 55.17% to $13.0 million in 2024, then tumbled by 107.69% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Other financing activities are -$1.0 million (Q4 2025), -$80.0 million (Q3 2025), and -$1.0 million (Q2 2025).